719.39
price down icon0.80%   -5.83
pre-market  시장 영업 전:  722.63   3.24   +0.45%
loading
전일 마감가:
$725.22
열려 있는:
$725.22
하루 거래량:
2.93M
Relative Volume:
0.73
시가총액:
$681.79B
수익:
$49.00B
순이익/손실:
$11.11B
주가수익비율:
58.53
EPS:
12.29
순현금흐름:
$-1.27B
1주 성능:
-0.77%
1개월 성능:
-18.00%
6개월 성능:
-8.73%
1년 성능:
-10.95%
1일 변동 폭
Value
$714.74
$729.99
1주일 범위
Value
$709.00
$731.31
52주 변동 폭
Value
$677.09
$972.53

일라이 릴리 Stock (LLY) Company Profile

Name
명칭
Lilly Eli Co
Name
전화
(317) 276-2000
Name
주소
LILLY CORPORATE CTR, INDIANAPOLIS, IN
Name
직원
47,000
Name
트위터
@LillyPad
Name
다음 수익 날짜
2024-10-30
Name
최신 SEC 제출 서류
Name
LLY's Discussions on Twitter

LLY을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - General icon
LLY
Lilly Eli Co
719.39 650.81B 49.00B 11.11B -1.27B 12.29
Drug Manufacturers - General icon
JNJ
Johnson Johnson
152.43 368.56B 89.33B 21.81B 18.57B 8.99
Drug Manufacturers - General icon
ABBV
Abbvie Inc
183.09 321.13B 57.37B 4.20B 15.39B 2.35
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
111.87 222.75B 53.22B 12.86B 14.85B 6.39
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
68.60 303.04B 43.59B 15.04B 10.74B 3.3766

일라이 릴리 Stock (LLY) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-28 다운그레이드 HSBC Securities Buy → Reduce
2025-04-22 개시 Cantor Fitzgerald Overweight
2024-12-10 재개 BofA Securities Buy
2024-11-15 개시 Wolfe Research Outperform
2024-10-17 개시 Bernstein Outperform
2024-09-13 재개 Citigroup Buy
2024-08-12 업그레이드 Deutsche Bank Hold → Buy
2024-02-21 다운그레이드 DZ Bank Buy → Hold
2024-02-16 재확인 Morgan Stanley Overweight
2023-12-21 다운그레이드 Daiwa Securities Buy → Outperform
2023-11-09 개시 Deutsche Bank Hold
2023-10-20 재개 UBS Buy
2023-08-09 업그레이드 Jefferies Hold → Buy
2023-07-26 재확인 Citigroup Buy
2023-07-14 개시 HSBC Securities Buy
2023-05-24 재확인 BofA Securities Buy
2023-05-24 재확인 UBS Buy
2023-03-13 업그레이드 Wells Fargo Equal Weight → Overweight
2023-03-06 개시 Jefferies Hold
2023-02-15 다운그레이드 Societe Generale Hold → Sell
2022-11-18 개시 Credit Suisse Outperform
2022-09-22 업그레이드 UBS Neutral → Buy
2022-05-23 개시 SVB Leerink Outperform
2022-04-06 재개 Morgan Stanley Overweight
2022-03-10 개시 Daiwa Securities Outperform
2022-01-21 업그레이드 DZ Bank Hold → Buy
2022-01-03 재확인 Bernstein Mkt Perform
2021-12-17 개시 Goldman Neutral
2021-12-16 재확인 BMO Capital Markets Outperform
2021-12-16 재확인 BofA Securities Buy
2021-12-09 재개 Wells Fargo Equal Weight
2021-11-19 개시 BMO Capital Markets Outperform
2021-10-11 업그레이드 Berenberg Hold → Buy
2021-09-29 업그레이드 Citigroup Neutral → Buy
2021-08-05 업그레이드 DZ Bank Hold → Buy
2021-07-27 재개 Truist Buy
2021-06-24 재확인 Cantor Fitzgerald Overweight
2021-01-19 업그레이드 Mizuho Neutral → Buy
2020-12-10 업그레이드 Wolfe Research Peer Perform → Outperform
2020-11-10 재개 Bernstein Mkt Perform
2020-09-29 개시 Berenberg Hold
2020-09-03 업그레이드 Morgan Stanley Equal-Weight → Overweight
2020-06-16 업그레이드 Guggenheim Neutral → Buy
2020-04-21 다운그레이드 UBS Buy → Neutral
2020-04-09 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-02-06 개시 Mizuho Neutral
2019-12-18 업그레이드 Morgan Stanley Equal-Weight → Overweight
2019-10-17 재개 BofA/Merrill Buy
2019-05-28 개시 Goldman Buy
2019-04-24 업그레이드 Edward Jones Hold → Buy
2019-04-11 다운그레이드 Guggenheim Buy → Neutral
2019-03-12 개시 JP Morgan Overweight
2019-01-23 개시 UBS Buy
2018-11-26 다운그레이드 Citigroup Buy → Neutral
2018-10-31 업그레이드 Credit Suisse Underperform → Neutral
2018-10-09 개시 Guggenheim Buy
2018-10-01 재확인 SunTrust Buy
2018-09-26 재개 JP Morgan Overweight
모두보기

일라이 릴리 주식(LLY)의 최신 뉴스

pulisher
May 28, 2025

The weight loss war: Who is winning out between Novo-Nordisk and Eli Lilly? - Shares Magazine

May 28, 2025
pulisher
May 28, 2025

‘Start a Position’ in Eli Lilly Stock (LLY), Says Jim Cramer - TipRanks

May 28, 2025
pulisher
May 28, 2025

Eli Lilly to Expand Pain Pipeline With $1B SiteOne Buyout Offer - TradingView

May 28, 2025
pulisher
May 28, 2025

BMO reiterates Eli Lilly stock with $900 target on SiteOne deal - Investing.com

May 28, 2025
pulisher
May 28, 2025

Eli Lilly vs. AstraZeneca: Which Pharma Powerhouse is the Better Buy? - The Globe and Mail

May 28, 2025
pulisher
May 28, 2025

Lilly seeks to expand pain pipeline with $1B acquisition - dailyjournal.net

May 28, 2025
pulisher
May 28, 2025

Lilly to acquire biotech developing pain drugs - statnews.com

May 28, 2025
pulisher
May 28, 2025

Reports: Lilly eyes Houston for new $5.9B manufacturing facility - Indianapolis Business Journal

May 28, 2025
pulisher
May 28, 2025

Lilly to acquire SiteOne Therapeutics to expand pain pipeline - World Pharmaceutical Frontiers

May 28, 2025
pulisher
May 28, 2025

Eli Lilly to expand pain portfolio with SiteOne acquisition - Cleanroom Technology

May 28, 2025
pulisher
May 28, 2025

Novo Nordisk's 52% Plunge: Is the Company Fumbling Its Leadership in the $150 Billion Weight Loss Market? - The Motley Fool

May 28, 2025
pulisher
May 27, 2025

Jim Cramer Notes Eli Lilly (LLY) Stock is at a “Decent Level to Start a Position” - Insider Monkey

May 27, 2025
pulisher
May 27, 2025

Lilly snags Peninsula non-opioid pain drug company for up to $1 billionSan Francisco Business Times - The Business Journals

May 27, 2025
pulisher
May 27, 2025

Eli Lilly Commits $1B to Get Drug That Could Rival Vertex’s New Non-Opioid Pain Med - MedCity News

May 27, 2025
pulisher
May 27, 2025

Lilly's Acquisition Of SiteOne Aims For Opioid AlternativesEli Lilly (NYSE:LLY) - Benzinga

May 27, 2025
pulisher
May 27, 2025

Eli Lilly Targets Pain Management Opportunity with SiteOne Therapeutics Acquisition - Insider Monkey

May 27, 2025
pulisher
May 27, 2025

Eli Lilly Inks $1B Deal For Non-Opioid Pain-Drug Maker - Law360

May 27, 2025
pulisher
May 27, 2025

Eli Lilly (LLY) Shows Strong Options Activity Amid Share Price Rise | LLY Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Eli Lilly to expand pain pipeline with $1bn SiteOne buyout - Pharmaceutical Technology

May 27, 2025
pulisher
May 27, 2025

Eli Lilly to buy SiteOne for $1 billion with eye on non-opioid pain drug - Reuters

May 27, 2025
pulisher
May 27, 2025

Eli Lilly’s Strategic Acquisition of SiteOne Therapeutics Bolsters Pain Management Portfolio and Supports Buy Rating - TipRanks

May 27, 2025
pulisher
May 27, 2025

Eli Lilly (LLY) Expands into Pain Management Through Acquisition | LLY Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Eli Lilly (LLY) to Acquire SiteOne Therapeutics for $1 Billion - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Eli Lilly expands neuroscience pipeline with $1B SiteOne acquisition - Proactive financial news

May 27, 2025
pulisher
May 27, 2025

Seven top pharmas posted revenue declines in Q1. The common thread? All are US firms - Fierce Pharma

May 27, 2025
pulisher
May 27, 2025

Eli Lilly To Acquire SiteOne Therapeutics For Up To $1B To Advance Pain Management Pipeline: But Retail’s Unconvinced By Stocktwits - Investing.com India

May 27, 2025
pulisher
May 27, 2025

Lilly to acquire SiteOne, enhancing non-opioid pain treatment options By Investing.com - Investing.com India

May 27, 2025
pulisher
May 27, 2025

Lilly to acquire SiteOne, enhancing non-opioid pain treatment options - Investing.com Australia

May 27, 2025
pulisher
May 27, 2025

Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics By Investing.com - Investing.com Nigeria

May 27, 2025
pulisher
May 27, 2025

Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics - Investing.com

May 27, 2025
pulisher
May 27, 2025

Eli Lilly (LLY) to Acquire SiteOne Therapeutics in $1 Billion De - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Eli Lilly’s SWOT analysis: stock poised for growth amid challenges - Investing.com

May 27, 2025
pulisher
May 27, 2025

Eli Lilly to acquire privately held SiteOne - Yahoo

May 27, 2025
pulisher
May 27, 2025

Eli Lilly & Co. (LLY) Acquires SiteOne Therapeutics - StreetInsider

May 27, 2025
pulisher
May 27, 2025

Lilly to expand its pain pipeline with acquisition of SiteOne Therapeutics | Eli Lilly and Company - Eli Lilly and Company

May 27, 2025
pulisher
May 27, 2025

Lilly Makes $1B Bet on Next-Generation Pain Treatment: Key Details of SiteOne Acquisition Revealed - Stock Titan

May 27, 2025
pulisher
May 27, 2025

Investment Case For Eli Lilly Still Weak, Despite Novo Nordisk's Struggle (NYSE:LLY) - Seeking Alpha

May 27, 2025
pulisher
May 27, 2025

Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

May 27, 2025
pulisher
May 27, 2025

Lilly's blood drive breaks site record - reporter.net

May 27, 2025
pulisher
May 27, 2025

Here's How the Pharmaceutical Import Tariffs Could Affect Eli Lilly - AOL.com

May 27, 2025
pulisher
May 26, 2025

Eli Lilly (LLY) Considers New $5.9 Billion Plant in Houston, Texas - TipRanks

May 26, 2025
pulisher
May 26, 2025

Prurigo Nodularis Market - GlobeNewswire Inc.

May 26, 2025
pulisher
May 25, 2025

Eli Lilly (LLY) Faces Lowered Market Forecast for Anti-Obesity D - GuruFocus

May 25, 2025
pulisher
May 24, 2025

Eli Lilly & Co (LLY) Gets a Buy from Bank of America Securities - The Globe and Mail

May 24, 2025
pulisher
May 23, 2025

Is Eli Lilly Stock A Sell After Novo Nordisk Wins An Unexpected Obesity Edge? - Investor's Business Daily

May 23, 2025
pulisher
May 23, 2025

Type 2 Diabetes Market to Expand Significantly by 2034, States DelveInsight Report | Eli Lilly and Company, Regor Pharma, AstraZeneca, Eccogene, Pfizer, Sciwind Biosciences USA Co., Ltd., MediciNova - The Globe and Mail

May 23, 2025
pulisher
May 23, 2025

With short film, Eli Lilly is Seeking to transform itself as a drugmaker - PR Week

May 23, 2025
pulisher
May 23, 2025

The Zacks Analyst Blog Highlights Eli Lilly, GE Aerospace and Amgen - Yahoo Finance

May 23, 2025
pulisher
May 22, 2025

Eli Lilly and Company (LLY) Gains Approval in Australia for Early Alzheimer’s Treatment - Insider Monkey

May 22, 2025
pulisher
May 22, 2025

Eli Lilly & Co. (LLY) gives presentation highlights for 2025 ASCO - StreetInsider

May 22, 2025
pulisher
May 22, 2025

Top Analyst Reports for Eli Lilly, GE Aerospace & Amgen - Yahoo Finance

May 22, 2025

일라이 릴리 (LLY) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
drug_manufacturers_general JNJ
$152.43
price down icon 0.54%
$183.09
price down icon 1.42%
drug_manufacturers_general NVS
$111.87
price down icon 1.18%
drug_manufacturers_general NVO
$68.60
price down icon 2.61%
drug_manufacturers_general MRK
$76.17
price down icon 1.83%
자본화:     |  볼륨(24시간):